Bowleven Share News (BLVN)

Bowleven One Step Away From Completing Etinde Farm-Out Deal

BowLeven To Drill First Well On Bomono Permit, Cameroon In February

BowLeven Secures Presidential Signature For Etinde Farm Out Deal

London close: Santa Rally continues as UK stocks rise for sixth straight day

UK stocks rose again on Tuesday as the Santa Rally continued into its sixth straight day, with markets boosted by some upbeat economic data from the States. Third-quarter US annualised gross domestic product (GDP) growth was revised to 5% from an initial estimate of 3.9%, representing the strongest

London midday: Stocks rise but gains pared after UK GDP data

UK stocks rose again on Tuesday as the pre-Christmas rally continued, though gains were trimmed by lunchtime after some disappointing data. On a day lacking of corporate news, investors were also showing caution ahead of a flurry of economic indicators Stateside. Stock futures on Wall Street were on

Bowleven sweats on Cameroon presidential signature

Cameroon-focused oil explorer Bowleven has allowed extra time for the completion of the farm-out agreement over its Etinde project as it continued to sweat over presidential approval. Having in October said the only remaining formality to the completion of the transaction was the gazetting of the si

Monday newspaper round-up: Aviva, Iran, AIM

An estimated 2,000 insurance jobs are likely to be axed as Aviva tries to placate scepticism about its bid for Friends Life. While some analysts hailed the £5.6bn deal announced on Friday evening as giving Aviva scope to push up its dividend, others were unimpressed, with one questioning whether it

Westhouse highlights attractive oil stocks that can weather crude-price falls

Westhouse Securities has called for investors in the oil and gas sector to be a "bit more patient" with oil prices currently rumbling along at multi-year lows, as it highlighted buying opportunities in the sector. Brent crude has now fallen over 25% to $79 a barrel since hitting a high of $115 a bar

Thursday broker round-up.-Update

AstraZeneca: JP Morgan raises target price from 3700p to 4100p, keeping its underweight rating. AVEVA Group: Barclays upgrades to overweight. Bellway: Credit Suisse raises target price from 1876p to 1905p and keeps a neutral rating. Bow Leven: Barclays shifts target price from 45p to 50p and retai

UK BROKER RATINGS: Berenberg Raises Wolseley To Buy From Hold

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

BowLeven Annual Loss Widens As It Focuses On Finalising Farm Outs

UK Earnings, Trading Statements Calendar - Week Ahead